Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicine for treating neurasthenia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A neurasthenia and drug technology, applied in the field of medicine, can solve problems such as unfavorable treatment, patient dependence, and large side effects
Inactive Publication Date: 2005-09-07
西安亨通光华制药有限公司
View PDF0 Cites 12 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, the treatment of this disease is mainly based on psychotherapy and drug therapy, among which anti-anxiety drugs, sedative-hypnotic drugs, β-receptor blockers and tricyclic drugs are used more. The improvement effect is not good, and the side effects are relatively large, it is easy to make patients form psychological dependence, which is not conducive to the progress of treatment
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0026] The preparation process of space mutagenesis strains to produce mannan peptides:
[0027] The mannan peptide produced by the space mutagenic strains of the present invention is prepared by the following method: preparation of space strains --- primary fermentation --- secondary fermentation --- fermentation liquid purification, and finally produce Mannan peptides.
[0031] The slant seed medium is sterilized at a temperature of 121°C for 30 minutes and a steam pressure of 0.12Mpa.
[0032] Unseal the strain freezing tube, dilute it with sterile broth medium, insert it into the blood slant under aseptic conditions, and culture it at 38°C for 30 hours after inocul...
Embodiment 1
[0086] Example 1 Take 300g of the above-mentioned α-mannan peptide, 100g of fried jujube kernels, 50g of Radix Polygalae, 50g of Schisandra chinensis, 70g of Uncaria elata, 50g of Gastrodia elata, 60g of amber, 50g of Coptis chinensis, 90g of Albizia Julibrissin, 80g of Ganoderma lucidum, 50g of calamus, and Baiziren Divide 50g into 10 bags of medicine, first decoct the above traditional Chinese medicine three times, mix the decoction, mix α-mannan peptide with the decoction; gelatinize at 90-100°C for 20-30 minutes, gelatinize The final slurry is in the form of a transparent paste; spread the above paste evenly on the enamel plate, the thickness is as consistent as possible and as thin as possible, and then dried at 110°C for 45-60 minutes; the above dried material is crushed with a pulverizer, Sieve through a 60-mesh sieve and pack into 10g / bag.
[0087] The specific production process is produced according to the preparation process of granules in the 2000 edition of the Ph...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention belongs to a medicine, especially a medicine synthesized by biological preparation and Chinese traditionalmedicine for treating neurasthenia, it is characterized in that is includes Alpha-mannan peptides 20%-60%, and Chinese traditional medicine of easing mind and soothing soul kind 40%-80%. The medicine includes Alpha-mannan peptides 20%-50%, Chinese traditional medicine of easing mind and soothing soul kind 10%-60%, and soothing liver regulating qi Chinese traditional medicine 10%-50%. The medicine includes Alpha-mannan peptides 20%-40%, Chinese traditional medicine of easing mind and soothing soul kind 10%-40%, soothing liver regulating qi Chinese traditional medicine 10%-30%, and supplementing qi and nourishing blood Chinese traditional medicine 10%-40%. The medicine for curing nervous prostration is compound recipe granular formulation composed of Alpha-mannan peptides produced by fermenting spatial mutagenesis bacterium and Chinese traditional medicine which has the function of soothing liver solving gloomy, regulating qi and strengthening the spleen, supplementing qi and nourishing blood, benefiting brain and inducing resuscitation and easing mind and soothing soul. The prescription of the invention is scientific and novel, and can combine the spatial biological technology with motherland traditional medicine, and play their cooperating function to produce a medicine without toxic and side effects and with high efficiency.
Description
Technical field [0001] The invention belongs to a medicine, in particular to a medicine synthesized from biological preparations and traditional Chinese medicines for treating neurasthenia. Background technique [0002] Neurasthenia is more common in young adults and mental workers. It is based on lack of self-confidence, poor self-control and relatively introverted personality. It is caused by long-term excessive mental stress due to overly heavy and difficult work or study, or long-term psychological conflicts. And the disease. Irregular life, insufficient physical exercise and other factors that weaken the function of the body often encourage the occurrence of the disease. The main symptoms are: ① Brain function decline: such as weakened thinking ability, inattention, loss of recent memory, unsustainable work and study, decreased efficiency, and easy fatigue. ②Emotional changes: easy to be agitated, sad or angry, and often caused by anxiety or depr...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.